Liposome drug delivery

Details Liposome drug delivery Liposome drug delivery

2008-06-17

2008-06-17

Kishore, Gollamudi S. (Department: 1612)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

C424S458000, C424S462000, C424S463000, C424S469000, C424S474000, C424S475000, C424S480000, C424S482000

Reexamination Certificate

active

07387791

ABSTRACT:
This invention comprises pharmaceutical compositions for administering a biologically active compound to an animal. Particularly provided are proliposomal compositions that are advantageously used to deliver biologically active compounds to the gastrointestinal tract after oral administration.

REFERENCES:
patent: 4302440 (1981-11-01), John et al.
patent: 4615885 (1986-10-01), Nakagame
patent: 4687762 (1987-08-01), Fukushima et al.
patent: 4744989 (1988-05-01), Payne et al.
patent: 4857337 (1989-08-01), Miller et al.
patent: 4921757 (1990-05-01), Wheatley et al.
patent: 4963526 (1990-10-01), Ecanow
patent: 5004611 (1991-04-01), Leigh
patent: 5043165 (1991-08-01), Radhakrishnan
patent: 5053217 (1991-10-01), Lehigh
patent: 5128139 (1992-07-01), Brown
patent: 5141674 (1992-08-01), Leigh
patent: 5223263 (1993-06-01), Hostetler et al.
patent: 5466468 (1995-11-01), Schneider et al.
patent: 5484809 (1996-01-01), Hostetler et al.
patent: 5580571 (1996-12-01), Hostetler et al.
patent: 5595756 (1997-01-01), Bally et al.
patent: 5610163 (1997-03-01), Banholzer et al.
patent: 5626869 (1997-05-01), Nyqvist et al.
patent: 5635206 (1997-06-01), Ganter et al.
patent: 5654314 (1997-08-01), Banholzer et al.
patent: 5665379 (1997-09-01), Herslof et al.
patent: 5738868 (1998-04-01), Shinkarenko
patent: 5744461 (1998-04-01), Hostetler et al.
patent: 5744592 (1998-04-01), Hostetler et al.
patent: 5756116 (1998-05-01), Hostetler et al.
patent: 5762904 (1998-06-01), Okada et al.
patent: 5770738 (1998-06-01), Banholzer et al.
patent: 5843509 (1998-12-01), Calvo Salve et al.
patent: 5955451 (1999-09-01), Lichtenberger et al.
patent: 5958450 (1999-09-01), Tashiro
patent: 6015576 (2000-01-01), See
patent: 6060082 (2000-05-01), Chen et al.
patent: 6093406 (2000-07-01), Alving
patent: 6117449 (2000-09-01), See et al.
patent: 6207185 (2001-03-01), See et al.
patent: 6207190 (2001-03-01), Richardson et al.
patent: 6231888 (2001-05-01), Lerner et al.
patent: 6761901 (2004-07-01), Betageri et al.
patent: 6824790 (2004-11-01), Yatvin
patent: 0 350 287 (1990-01-01), None
patent: 0 736 299 (1996-10-01), None
patent: 0 855 179 (1998-07-01), None
patent: 0855179 (1998-07-01), None
patent: 2 581 543 (1986-07-01), None
patent: 2581543 (1986-07-01), None
patent: WO 89/02733 (1989-04-01), None
patent: WO 93/00910 (1993-01-01), None
patent: 94/28876 (1994-12-01), None
patent: WO 94/28876 (1994-12-01), None
patent: WO 95/03035 (1995-02-01), None
patent: WO 96/39121 (1996-12-01), None
patent: WO 97/12580 (1997-04-01), None
patent: WO 00/28989 (2000-05-01), None
patent: WO 01/82897 (2001-11-01), None
patent: WO 02/13782 (2002-02-01), None
patent: WO 03/059288 (2003-07-01), None
patent: WO 03/099261 (2003-12-01), None
patent: WO 2006/062544 (2006-06-01), None
Katare et al “Proliposomes of indomethacin for oral administration”, 1991, J. Microencapsulation, 81: 1-7.
Rahman et al., “Differential Uptake of Liposomes Varying in Size and Lipid Composition by Parenchymal and Kupffer Cells of Mouse Liver”, Life Sciences, vol. 31, pp. 2061-2071 (1982).
Gregoriadis, Gregory, “Engineering Liposomes for Drug Delivery: Progress and Problems”, Trends in Biotechnology, vol. 13, pp. 527-537 (1995).
Ledley, Fred D., “NonViral Gene Therapy: The Promise of Genes as Pharmaceutical Products”, Human Gene Therapy, vol. 6, pp. 1129-1144 (1995).
Mickisch, G.H., “Gene Therapy on Renal-Cell Carcinoma: Magic Bullet or Tragic Insanity”, World J. Urology, vol. 13, pp. 178-185 (1995).
Yang, K. et al., “Gene Therapy for Central Nervous System Injury: The Use of Cationic Liposomes: An Invited Review”, Journal of Neurotrauma, vol. 14, No. 5, pp. 281-297 (1997).
Storm, G. et al., “Colloidal Systems for Tumor Targeting”, Hybridoma, vol. 16, No. 1, pp. 119-125 (1997).
Manusama, Eric R., “Tumor Necrosis Factor-Alpha in Isolated Perfusion Systems in the Treatment of Cancer: the Rotterdam Preclinical-Clinical Program”, Seminars in Surgical Oncology, vol. 14, pp. 232-237 (1998).
Katare, O.P. et al., “Proliposomes of Indomethacin for Oral Administration”, J. Microencapsulation, vol. 8, No. 1, pp. 1-7 (1991).
Kulkarne, S.B. et al., “Protamine-Induced Aggregation of Unilamellar Liposomes”, Pharm. Sci., vol. 1, pp. 359-362, (1995).
Embretson, Janet et al., “Massive Covert Infection of Helper T Lymphocytes and Macrophages by HIV During the Incubation Period of AIDS”, Nature, vol. 362, pp. 359-362 (1993).
Kanno, Hiroyuki et al., “Aleutian Mink Disease Parvovirus Infection of Mink Peritoneal Macrophages and Human Macrophage Cell Lines”, J. Virol., vol. 67, No. 4, pp. 2075-2082 (1993).
Kanno, Hiroyuki e al., “Identification of Aleutian Mink Disease Parvovirus Transcripts in Macrophages of Infected Adult Mink”, J. Virol., vol. 66, No. 9, pp. 5305-5312 (1992).
Maciejewski, Jaroslaw et al., “Infection of Mononucleated Phagocytes with Human Cytomegalovirus”, Virology, vol. 195, pp. 327-336 (1993).
Meltzer, M.S. et al., “Mononuclear Phagocytes as Targets, Tissue Reservoirs, and Immunoregulatory Cells in Human Immunodeficiency Virus Disease”, Curr. Top. Microbiol Immunol., vol. 181, pp. 239-263 (1992).
Sierra-Honigmann et al., “Borna Disease Virus in Peripheral Blood Mononuclear and Bone Marrow Cells of Neonatally and Chronically Infected Rats”, J. Neuroimmunology, vol. 45, pp. 31-36 (1993).
Sturgill-Koszycki et al., “Lack of Acidification in Mycobacterium Phagosomes Produced by Exclusion of the Vasicular Proton-ATPase”, Science, vol. 263, pp. 678-681 (1994).
Alvarez-Dominguez, Carmen et al., “Role of Complement Component C1q in Phagocytosis of Listeria Monocytogenes by Murine Macrophase-Like Cell Lines”, Infect. Immun., vol. 61, No. 9, pp. 3664-3672 (1993).
Bignami, Gary S. et al., “N-(4′-Hydroxyphenylacetyl) Palytoxin: A Palytoxin Prodrug That Can Be Activated by a Monoclonal Antibody-Penicillin G Amidase Conjugate”, Cancer Research, vol. 52, pp. 5759-5764 (1992).
Kumar et al., “Formulation, Characterization and In Vitro Release of Glyburide from Proliposomal Beads”, Database Accession No. 2001082693, XP002184270 (2001).
Payne, Nicholas I. et al., “Proliposomes: A Novel Solution to an Old Problem”, Journal of Pharmaceutical Sciences, vol. 75, No. 4, pp. 325-326 (Apr. 1986).
Oku, N. et al., “Effect of Freeze-Thawing on Phospholipid/Surfactant Mixed Bilayers”, Chemical and Pharmaceutical Bulletin, Pharmaceutical Society of Japan, Tokyo, JP 44(10) 1928-30 (1996).

Affiliated with

Also associated with

Rating

Liposome drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Liposome drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposome drug delivery will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2809773